Your browser doesn't support javascript.
loading
Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention.
Karim, Quarraisha Abdool; Archary, Derseree; Barré-Sinoussi, Françoise; Broliden, Kristina; Cabrera, Cecilia; Chiodi, Francesca; Fidler, Sarah J; Gengiah, Tanuja N; Herrera, Carolina; Kharsany, Ayesha B M; Liebenberg, Lenine J P; Mahomed, Sharana; Menu, Elisabeth; Moog, Christiane; Scarlatti, Gabriella; Seddiki, Nabila; Sivro, Aida; Cavarelli, Mariangela.
Afiliación
  • Karim QA; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2Floor), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Archary D; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.
  • Barré-Sinoussi F; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2Floor), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Broliden K; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Cabrera C; Institut Pasteur, Paris, France.
  • Chiodi F; Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Department of Infectious Diseases, Karolinska University Hospital, Center for Molecular Medicine, Stockholm, Sweden.
  • Fidler SJ; AIDS Research Institute IrsiCaixa, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Gengiah TN; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Herrera C; Department of Infectious Disease, Faculty of Medicine, Imperial College London UK and Imperial College NIHR BRC, London, United Kingdom.
  • Kharsany ABM; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2Floor), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Liebenberg LJP; Department of Infectious Disease, Section of Virology, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Mahomed S; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2Floor), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Menu E; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Moog C; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2Floor), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Scarlatti G; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Seddiki N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2Floor), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Sivro A; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Cavarelli M; MISTIC Group, Department of Virology, Institut Pasteur, Paris, France.
Front Immunol ; 13: 1055042, 2022.
Article en En | MEDLINE | ID: mdl-36561760

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Female / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Female / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica